RIG-I Modulates Src-Mediated AKT Activation to Restrain Leukemic Stemness

Molecular Cell

Volumn 53, Issue 3, 2014, Pages 407-419

  Li, Xian Yang ^a,b   Jiang, Lin Jia ^a,b   Chen, Lei ^a,b   Ding, Meng Lei ^a,b   Guo, He Zhou ^a,b   Zhang, Wu ^a,b   Zhang, Hong Xin ^b   Ma, Xiao Dan ^a   Liu, Xiang Zhen ^a   Xi, Xiao Dong ^a   Chen, Sai Juan ^a   Chen, Zhu ^a   Zhu, Jiang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai E Institute for Model Organisms   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; MAMMALIAN TARGET OF RAPAMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; MALIGNANT TRANSFORMATION; MYELOID PROGENITOR CELL; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL SIZE; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; ENZYME ACTIVATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84893796412     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.12.008     Document Type: Article

References (54)

1. Belgnaoui S.M., Paz S., Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr. Opin. Immunol. 2011, 23:564-572.
2. Besch R., Poeck H., Hohenauer T., Senft D., Häcker G., Berking C., Hornung V., Endres S., Ruzicka T., Rothenfusser S., Hartmann G. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J.Clin. Invest. 2009, 119:2399-2411.
3. Birnbaum R.A., O'Marcaigh A., Wardak Z., Zhang Y.Y., Dranoff G., Jacks T., Clapp D.W., Shannon K.M. Nf1 and Gmcsf interact in myeloid leukemogenesis. Mol. Cell 2000, 5:189-195.
4. Boggon T.J., Eck M.J. Structure and regulation of Src family kinases. Oncogene 2004, 23:7918-7927.
5. Carracedo A., Pandolfi P.P. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 2008, 27:5527-5541.
6. Chen R., Kim O., Yang J., Sato K., Eisenmann K.M., McCarthy J., Chen H., Qiu Y. Regulation of Akt/PKB activation by tyrosine phosphorylation. J.Biol. Chem. 2001, 276:31858-31862.
7. Cui S., Eisenächer K., Kirchhofer A., Brzózka K., Lammens A., Lammens K., Fujita T., Conzelmann K.K., Krug A., Hopfner K.P. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol. Cell 2008, 29:169-179.
8. Dos Santos C., Demur C., Bardet V., Prade-Houdellier N., Payrastre B., Récher C. A critical role for Lyn in acute myeloid leukemia. Blood 2008, 111:2269-2279.
9. Fujita T. A nonself RNA pattern: tri-p to panhandle. Immunity 2009, 31:4-5.
10. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
11. Gallay N., Dos Santos C., Cuzin L., Bousquet M., Simmonet Gouy V., Chaussade C., Attal M., Payrastre B., Demur C., Récher C. The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia. Leukemia 2009, 23:1029-1038.
12. Gee P., Chua P.K., Gevorkyan J., Klumpp K., Najera I., Swinney D.C., Deval J. Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J.Biol. Chem. 2008, 283:9488-9496.
13. Gery S., Park D.J., Vuong P.T., Virk R.K., Muller C.I., Hofmann W.K., Koeffler H.P. RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation. Exp. Hematol. 2007, 35:572-578.
14. Goubau D., Deddouche S., Reis E Sousa C. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
15. Green W.B., Slovak M.L., Chen I.M., Pallavicini M., Hecht J.L., Willman C.L. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31). Leukemia 1999, 13:1960-1971.
16. Horn S., Meyer J., Stocking C., Ostertag W., Jücker M. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1). Oncogene 2003, 22:7170-7180.
17. Isakson P., Bjørås M., Bøe S.O., Simonsen A. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood 2010, 116:2324-2331.
18. Jiang T., Qiu Y. Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J.Biol. Chem. 2003, 278:15789-15793.
19. Jiang L.J., Zhang N.N., Ding F., Li X.Y., Chen L., Zhang H.X., Zhang W., Chen S.J., Wang Z.G., Li J.M., et al. RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc. Natl. Acad. Sci. USA 2011, 108:1897-1902.
20. Johnsen I.B., Nguyen T.T., Bergstroem B., Fitzgerald K.A., Anthonsen M.W. The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling. J.Biol. Chem. 2009, 284:19122-19131.
21. Kannan-Thulasiraman P., Dolniak B., Kaur S., Sassano A., Kalvakolanu D.V., Hay N., Platanias L.C. Role of the translational repressor 4E-BP1 in the regulation of p21(Waf1/Cip1) expression by retinoids. Biochem. Biophys. Res. Commun. 2008, 368:983-989.
22. Kaur S., Katsoulidis E., Platanias L.C. Akt and mRNA translation by interferons. Cell Cycle 2008, 7:2112-2116.
23. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
24. Kharas M.G., Okabe R., Ganis J.J., Gozo M., Khandan T., Paktinat M., Gilliland D.G., Gritsman K. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 2010, 115:1406-1415.
25. Kim L.C., Song L., Haura E.B. Src kinases as therapeutic targets for cancer. Nat. Rev. Clin. Oncol. 2009, 6:587-595.
26. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 2007, 8:931-937.
27. Kong L., Sun L., Zhang H., Liu Q., Liu Y., Qin L., Shi G., Hu J.H., Xu A., Sun Y.P., et al. An essential role for RIG-I in toll-like receptor-stimulated phagocytosis. Cell Host Microbe 2009, 6:150-161.
28. Lal L., Li Y., Smith J., Sassano A., Uddin S., Parmar S., Tallman M.S., Minucci S., Hay N., Platanias L.C. Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood 2005, 105:1669-1677.
29. Levine B., Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 2007, 7:767-777.
30. Liang J., Shao S.H., Xu Z.X., Hennessy B., Ding Z., Larrea M., Kondo S., Dumont D.J., Gutterman J.U., Walker C.L., et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 2007, 9:218-224.
31. Lodeiro M., Theodoropoulou M., Pardo M., Casanueva F.F., Camiña J.P. c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS ONE 2009, 4:e4686.
32. Luan B., Zhao J., Wu H., Duan B., Shu G., Wang X., Li D., Jia W., Kang J., Pei G. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 2009, 457:1146-1149.
33. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8:741-752.
34. Martelli A.M., Evangelisti C., Chiarini F., McCubrey J.A. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. Oncotarget 2010, 1:89-103.
35. Martelli A.M., Evangelisti C., Follo M.Y., Ramazzotti G., Fini M., Giardino R., Manzoli L., McCubrey J.A., Cocco L. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells. Curr. Med. Chem. 2011, 18:2715-2726.
36. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
37. Mukherjee A., Morosky S.A., Shen L., Weber C.R., Turner J.R., Kim K.S., Wang T., Coyne C.B. Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions. J.Biol. Chem. 2009, 284:6486-6494.
38. O'Neill L.A., Bowie A.G. The powerstroke and camshaft of the RIG-I antiviral RNA detection machine. Cell 2011, 147:259-261.
39. Ohanna M., Sobering A.K., Lapointe T., Lorenzo L., Praud C., Petroulakis E., Sonenberg N., Kelly P.A., Sotiropoulos A., Pende M. Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol. 2005, 7:286-294.
40. Ozawa Y., Williams A.H., Estes M.L., Matsushita N., Boschelli F., Jove R., List A.F. Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leuk. Res. 2008, 32:893-903.
41. Perugini M., Brown A.L., Salerno D.G., Booker G.W., Stojkoski C., Hercus T.R., Lopez A.F., Hibbs M.L., Gonda T.J., D'Andrea R.J. Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. Blood 2010, 115:3346-3353.
42. Pleiman C.M., Hertz W.M., Cambier J.C. Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit. Science 1994, 263:1609-1612.
43. Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschläger N., Schlee M., Rothenfusser S., Barchet W., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol. 2010, 11:63-69.
44. Schenk T., Chen W.C., Göllner S., Howell L., Jin L., Hebestreit K., Klein H.U., Popescu A.C., Burnett A., Mills K., et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 2012, 18:605-611.
45. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
46. Song J.J., Kim J.H., Sun B.K., Alcala M.A., Bartlett D.L., Lee Y.J. c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment. Cell. Signal. 2010, 22:377-385.
47. Su Z.Z., Sarkar D., Emdad L., Barral P.M., Fisher P.B. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. J.Cell. Physiol. 2007, 213:502-510.
48. Suh H.S., Kim M.O., Lee S.C. Inhibition of granulocyte-macrophage colony-stimulating factor signaling and microglial proliferation by anti-CD45RO: role of Hck tyrosine kinase and phosphatidylinositol 3-kinase/Akt. J.Immunol. 2005, 174:2712-2719.
49. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 2005, 19:727-740.
50. Xu Y., Kim S.O., Li Y., Han J. Autophagy contributes to caspase-independent macrophage cell death. J.Biol. Chem. 2006, 281:19179-19187.
51. Yilmaz O.H., Valdez R., Theisen B.K., Guo W., Ferguson D.O., Wu H., Morrison S.J. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482.
52. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.
53. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., Xu M., Chen Z.J. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
54. Zhang N.N., Shen S.H., Jiang L.J., Zhang W., Zhang H.X., Sun Y.P., Li X.Y., Huang Q.H., Ge B.X., Chen S.J., et al. RIG-I plays a critical role in negatively regulating granulocytic proliferation. Proc. Natl. Acad. Sci. USA 2008, 105:10553-10558.